study cohort on TMA (n = 2710) | |
---|---|
follow up | 512 |
months | |
mean | 19.3 |
median | 13.0 |
pathological tumor stage | |
pTa | 887 (39.2%) |
pT2 | 462 (20.4%) |
pT3 | 615 (27.2%) |
pT4 | 298 (13.2%) |
tumor grade | |
G2 | 820 (30.6%) |
G3 | 1858 (69.4%) |
pathological lymph node status | |
pN0 | 734 (62.0%) |
pN+ | 449 (38.0%) |
resection margin status | |
R0 | 595 (80.6%) |
R1 | 143 (19.4%) |
lymphatic vessel infiltration | |
L0 | 275 (49.5%) |
L1 | 281 (50.5%) |
blood vessel infiltration | |
V0 | 450 (74.4%) |
V1 | 155 (25.6%) |